Evercore ISI Group Initiates Coverage On ProQR Therapeutics with Outperform Rating, Announces Price Target of $5
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on ProQR Therapeutics (NASDAQ:PRQR) with a Outperform rating and announces Price Target of $5.
Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on ProQR Therapeutics (NASDAQ:PRQR) with a Outperform rating and announces Price Target of $5.